Synthego Launches Engineered Cell Libraries to Validate Targets with Speed and Accelerate Drug Discovery

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Synthego, the genome engineering company, today announced the launch of Engineered Cell Libraries, a novel offering that further enables access to CRISPR by providing arrayed CRISPR-edited cells for direct use in functional screening assays. The innovative solution leverages Synthego’s Eclipse™ Platform. This high-throughput cell engineering platform delivers...

Click to view original post